These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20959972)

  • 1. Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.
    Barbier C; Chabernaud C; Barantin L; Bertrand P; Sembely C; Sirinelli D; Castelnau P; Cottier JP
    Neuroradiology; 2011 Feb; 53(2):141-8. PubMed ID: 20959972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.
    Wang PY; Kaufmann WE; Koth CW; Denckla MB; Barker PB
    Ann Neurol; 2000 Apr; 47(4):477-84. PubMed ID: 10762159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial MR imaging and 1H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1.
    Imamura A; Matsuo N; Okuda M; Morita H; Iwata M; Yamazaki Y; Takahashi Y
    Brain Dev; 2005 Dec; 27(8):595-7. PubMed ID: 15878248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the basal ganglia in neurofibromatosis type 1.
    Nicita F; Di Biasi C; Sollaku S; Cecchini S; Salpietro V; Pittalis A; Papetti L; Ursitti F; Ulgiati F; Zicari AM; Gualdi GF; Properzi E; Duse M; Ruggieri M; Spalice A
    Childs Nerv Syst; 2014 Feb; 30(2):319-25. PubMed ID: 23892392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.
    Billiet T; Mädler B; D'Arco F; Peeters R; Deprez S; Plasschaert E; Leemans A; Zhang H; den Bergh BV; Vandenbulcke M; Legius E; Sunaert S; Emsell L
    Neuroimage Clin; 2014; 4():649-58. PubMed ID: 24936416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis.
    Sharma KR; Saigal G; Maudsley AA; Govind V
    NMR Biomed; 2011 Dec; 24(10):1270-6. PubMed ID: 21404355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1.
    Gonen O; Wang ZJ; Viswanathan AK; Molloy PT; Zimmerman RA
    AJNR Am J Neuroradiol; 1999 Aug; 20(7):1333-41. PubMed ID: 10472995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.
    Ferraz-Filho JR; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Pediatr Radiol; 2012 Apr; 42(4):449-54. PubMed ID: 22033857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
    Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.
    Tognini G; Ferrozzi F; Garlaschi G; Piazza P; Patti A; Virdis R; Bertolino C; Bertolino G; Manfredini D; Zompatori M; Crisi G
    J Comput Assist Tomogr; 2005; 29(3):298-304. PubMed ID: 15891494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences.
    Kallenberg K; Schulz-Schaeffer WJ; Jastrow U; Poser S; Meissner B; Tschampa HJ; Zerr I; Knauth M
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1459-62. PubMed ID: 16908558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
    Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
    Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
    Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1.
    Alkan A; Sarac K; Kutlu R; Yakinci C; Sigirci A; Aslan M; Ozcan H; Yologlu S
    Magn Reson Imaging; 2003 Nov; 21(9):1049-53. PubMed ID: 14684211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1.
    Kraut MA; Gerring JP; Cooper KL; Thompson RE; Denckla MB; Kaufmann WE
    Am J Med Genet A; 2004 Aug; 129A(2):113-9. PubMed ID: 15316979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep gray matter structures in HIV infection: a proton MR spectroscopic study.
    Meyerhoff DJ; Weiner MW; Fein G
    AJNR Am J Neuroradiol; 1996 May; 17(5):973-8. PubMed ID: 8733976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megalencephaly in NF1: predominantly white matter contribution and mitigation by ADHD.
    Cutting LE; Cooper KL; Koth CW; Mostofsky SH; Kates WR; Denckla MB; Kaufmann WE
    Neurology; 2002 Nov; 59(9):1388-94. PubMed ID: 12427889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germinomas of the basal ganglia and thalamus: MR findings and a comparison between MR and CT.
    Moon WK; Chang KH; Kim IO; Han MH; Choi CG; Suh DC; Yoo SJ; Han MC
    AJR Am J Roentgenol; 1994 Jun; 162(6):1413-7. PubMed ID: 8192009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.